Everolimus-eluting bioresorbablecoronary scaffold in Asian patients; a 2-yearfollow-up
Abstract Indo-Pakistan population has one of the highest risk of coronary artery disease(CAD) in the world.1Percutaneous interventions with the use of stents has been the mainstay of treatment for CAD, evolving from balloon angioplasty to bare metal stents and then to drug eluting stents. Howeve...
Main Authors: | Muhammad Abdul Salam Azad, Uzma Gul, Asim Javed |
---|---|
Format: | Article |
Language: | English |
Published: |
Pakistan Medical Association
2020-11-01
|
Series: | Journal of the Pakistan Medical Association |
Online Access: | https://www.ojs.jpma.org.pk/index.php/public_html/article/view/1931 |
Similar Items
-
Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds – an optical coherence tomography substudy of the EVERBIO II trial
by: Zacharenia Kallinikou, et al.
Published: (2016-01-01) -
Everolimus-eluting stents in interventional cardiology
by: Townsend JC, et al.
Published: (2012-06-01) -
Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study
by: T. M. Hommels, et al.
Published: (2019-03-01) -
Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
by: Iraj Jafaripour, et al.
Published: (2023-05-01) -
Effects of Everolimus-Eluting Stents on the Left Ventricular Systolic and Diastolic Functions
by: MohammadSadegh Parsaee, et al.
Published: (2015-10-01)